Childhood haemorrhagic stroke: a 7-year single-centre experience by Gerstl, L et al.
	 1	
Childhood	haemorrhagic	stroke	–	A	7	years	single	center	experience		
Lucia	Gerstl1,	Katharina	Badura1,	Florian	Heinen1,	Raphael	Weinberger2,	Aurelia	Peraud3,	
Franziska	Dorn4,	Michaela	V.	Bonfert1,	Steffen	Berweck1,5,	Finbar	J	O´Callaghan6	
	
	
		
1	LMU	 Munich,	 University	 Hospital,	 Dr.	 von	 Hauner	 Children`s	 Hospital,	 Department	 of	
Paediatric	 Neurology	 and	 Developmental	 Medicine,	 Lindwurmstr.	 4,	 80337	 Munich,	
Germany	
2	LMU	 Munich,	 Institute	 of	 Social	 Paediatrics	 and	 Adolescent	 Medicine,	 Division	 of	
Epidemiology,	Haydnstr.	5,	80336	Munich,	Germany		
3	Department	of	Paediatric	Neurosurgery,	University	Hospital	Ulm,	Albert-Einstein-Allee	23,	
89081	Ulm,	Germany	
4	LMU	Munich,	University	Hospital,	Department	of	Neuroradiology,	Marchioninistr.15,	81377	
Munich,	Germany		
5	Clinic	 for	 Neuropaediatrics	 and	 Neurorehabilitation,	 Schön	 Klinik	
Vogtareuth,	Krankenhausstraße	20,	83569	Vogtareuth,	Germany	
6University	College	London,	 Institute	of	Child	Health,	Clinical	Neuroscience	Section,	London	
WC1N	1EH,	UK	
	
	
	
	
	
Correspondence	to	
Prof.	Finbar	O´Callaghan	
Professor	of	Paediatric	Neuroscience	
Head	of	Clinical	Neurosciences	Section	
Rm	41,	4th	Floor	PUW	South	
Institute	of	Child	Health	
University	College	London		
London	WC1N	1EH	
	
Tel:	+44	207	905	2927	
E-mail:	f.o’callaghan@ucl.ac.uk	
	
	
	
	
	 2	
Abstract	
Background:	 In	 recent	 years,	 there	 has	 been	 increasing	 research	 interest	 in	 improving	
diagnostic	and	management	protocols	in	childhood	arterial	ischaemic	stroke	(AIS).	However,	
childhood	 stroke	 comprises,	 in	 approximately	 equal	 parts,	 both	 arterial	 ischaemic	 and	
haemorrhagic	stroke	(HS).		
Objective:	 The	 aim	 of	 this	 study	 was	 to	 focus	 on	 the	 aetiology,	 clinical	 presentation,	
treatment	and	short-term	outcome	of	children	with	spontaneous	 intracranial	bleeding	 in	a	
university	hospital	and	elucidate	differences	to	childhood	arterial	ischaemic	stroke.		
Design:	We	performed	a	retrospective	analysis	of	electronic	medical	records	of	children	(28	
days	–	18	years)	diagnosed	with	haemorrhagic	stroke	between	2010	and	2016.		
Results:	 We	 included	 25	 children	 (male	 n=11)	 with	 a	 median	 age	 of	 8y1m.	 The	 most	
common	 clinical	 presentations	were	 vomiting	 (48%),	 headache	 (40%)	 and	 altered	 level	 of	
consciousness	(32%).	In	more	than	half	of	the	patients	haemorrhagic	stroke	was	caused	by	
vascular	 malformations.	 Other	 risk	 factors	 were	 brain	 tumour,	 coagulopathy	 and	
miscellaneous	severe	underlying	diseases.	Aetiology	remained	unclear	in	one	child.	Therapy	
was	neurosurgical	 in	most	 children	 (68%).	 Two	patients	died,	 five	patients	needed	 further	
(rehabilitation)	treatment	and	18	children	could	be	discharged	home.	
Conclusions:	Haemorrhagic	 stroke	differs	 from	AIS	 in	aetiology	 (vascular	malformations	as	
number	 1	 risk	 factor),	 number	 of	 risk	 factors	 (“mono-risk”	 disease),	 clinical	 presentation	
(vomiting,	headache	and	altered	level	of	consciousness)	and	(emergency)	therapy.		
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1.	Introduction	
Childhood	stroke	occurs	with	an	incidence	of	1,3-8/100	000	children/year,	approximately	as	
often	as	brain	tumours,	and	is	among	the	top	ten	of	mortality	in	children	1-4.	Primary	strokes	
may	be	either	arterial	ischaemic	strokes	(AIS)	that	are	caused	by	a	blocked	arterial	supply	or	
venous	 (=	 cerebral	 venous	 sinus	 thrombosis)	 or	 haemorrhagic,	 when	 they	 are	 defined	 as	
nontraumatic	spontaneous	intracranial	bleeding.	There	has	been	increasing	research	activity	
in	 the	 field	 of	 childhood	 arterial	 ischaemic	 stroke	 in	 recent	 years:	 Understanding	 the	
underlying	 pathological	 mechanisms	 (e.g.	 focal	 cerebral	 arteriopathy),	 acute	 treatment	
options	 (e.g.	 iv	 thrombolysis	 and	 mechanical	 thrombectomy)	 and	 reducing	 the	 time	 gap	
between	clinical	onset	and	diagnosis	by	using	appropriate	imaging	modalities	are	examples	
of	 ongoing	 research	 5-11.	 There	 has	 been	 less	 research	 interest	 in	 and	 awareness	 of	
haemorrhagic	stroke	(HS),	although	it	accounts	for	almost	half	of	all	childhood	strokes.		
Therefore,	 we	 aimed	 to	 describe	 a	 paediatric	 cohort	 with	 HS	 with	 respect	 to	 clinical	
presentation,	aetiology	and	short-term	outcome	and	point	out		the	differences	to	childhood	
AIS.	 These	 data	 could	 support	 paediatricians	 in	 their	 clinical	 assessment	 and	 diagnostic	
investigation	of	children	presenting	with	possible	HS.	
	
2.	Method	
We	 performed	 a	 retrospective	 review	 of	 electronic	 medical	 records	 of	 children	 with	
haemorrhagic	stroke	in	a	tertiary	university	children`s	hospital	in	Munich,	Germany	between	
January	 2010	 -	December	 2016.	 This	 university	 children`s	 hospital	 provides,	 together	with	
another	 university	 hospital	 and	 two	 other	 children`s	 hospitals,	 acute	 medical	 advice	 for	
231.510	children	from	0-18	years	(overall	population	of	Munich	in	2017:		1.456.039)12	.		
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Inclusion	criteria	was	the	diagnosis	of	an	haemorrhagic	stroke	defined	as	spontaneous,	non-
traumatic	 intracranial	 bleeding	 (intraparenchymal,	 ventricular	or	 subarachnoid)	 in	 children	
and	 adolescents	 (≥28	days	 of	 life	≤18	 years).	 As	 it	 remains	 unclear	whether	 children	who	
bleed	 in	a	brain	 tumour	are	 subsumed	under	 the	 term	 `haemorrhagic	 stroke`,	we	decided	
only	 to	 include	 those	 patients	 with	 a	 brain	 tumour,	 who	 bled	 into	 brain	 parenchyma,	
ventricles	or	subarachnoid	space.	Exclusion	criteria	were	perinatal	/	neonatal	haemorrhage	
(<28	 days	 of	 life),	 primary	 subdural	 or	 epidural	 bleeding,	 traumatic	 intracranial	 bleeding,	
haemorrhagic	transformation	of	AIS	or	secondary	HS	due	to	a	venous	infarction.		
Patients	eligible	for	inclusion	were	identified	via	ICD-10	codes	(international	classification	of	
diseases)	given	by	the	treating	paediatrician.	In	order	to	ensure	as	complete	data	collection	
as	possible,	we	used	a	broad	spectrum	of	ICD-10	codes	(see	table	1).	
In	total,	290	children	were	identified	applying	the	abovementioned	ICD-10	criteria	and	their	
electronic	medical	 records	were	 further	 reviewed	 to	 see	whether	 they	met	 the	 inclusion	 -	
exclusion	criteria	as	shown	in	figure	1.		
	
Collected	 information	 included	demographic	data,	 clinical	 presentation,	 aetiology,	 imaging	
modality,	acute	treatment	and	short-term	outcome	with	respect	to	discharge	from	hospital.		
	
Ethical	approval	
The	study	was	approved	by	the	ethics	committee	and	data	protection	commissioner	of	the	
Medical	Faculty	of	the	Ludwig-Maximilians-University	Munich,	Nr	756-16	(06-12-16).		
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3.	Results	
Patients	
The	study	group	consisted	of	25	patients.	Sex	ratio	was	m:f	=	0.8:1.	Median	age	at	the	time	
of	bleeding	was	8	years	1month	(range	1	month	–	16years	9months)	.	
	
Clinical	presentation	
The	presenting	features	of	the	children	are	presented	in	tables	2	and	3.		
Most	 children	 presented	 with	 vomiting	 (48%),	 headache	 (40%)	 and	 altered	 level	 of	
consciousness	 (32%),	 followed	 by	 seizures	 (28%)	 brainstem	 symptoms	 (16%),	 and	 acute	
hemiparesis	 (12%).	 One	 child,	 receiving	 extracorporeal	 mebrane	 oxygenation	 on	 the	
intensive	 care	 unit,	 showed	 signs	 of	 increased	 intracranial	 pressure.	 All	 three	 infants	 (i.e.	
<1year	 of	 age)	 with	 intracranial	 bleeding	 presented	 with	 vomiting.	 One	 infant	 also	 had	
seizures.		
Three	children	suffered	a	“silent”	stroke,	meaning	that	the	haemorrhage	was	an	incidental	
finding	in	otherwise	indicated	neuroimaging.		The	reasons	for	neuroimaging	were:	(i)	routine		
MRI	screening	in	a	child	with	known	multiple	cavernoma;	(ii)	MRI	in	a	child	with	a	suspected	
transient	 ischemic	 attack	 (clinical	 symptoms	 were	 not	 explained	 by	 the	 diagnosed	
cavernoma:	 localisation	 of	 the	 cavernoma:	 right	 frontal	 lobe;	 clinical	 symptoms:	 speech	
disturbance	 and	 right-sided	 hemiparesis)	 and	 (iii)	 a	 CT	 scan	 in	 a	 child	 to	 exclude	 cerebral	
oedema	after	cardiopulmonary	resuscitation.		
	
Aetiology	
Vascular	malformations	 were	 the	most	 common	 underlying	 aetiology	 (n=13),	 but	 did	 not	
occur	 as	 haemorrhage	 in	 children	 in	 the	 first	 year	 of	 life.	We	 identified	 six	 children	 with	
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haemorrhage	 due	 to	 arteriovenous	 malformations	 (AVM)	 and	 seven	 children	 with	
cavernoma,	 but	 no	 patient	 with	 bleeding	 from	 an	 intracranial	 aneurysm.	 Further	
characteristics	of	these	patients	with	vascular	malformation	are	provided	in	table	3.		
Patients	with	a	brain	tumour	who	bled	into	parenchyma	or	ventricles	represent	the	second	
largest	 group	 (n=5).	 Brain	 tumours	 were	 histopathologically	 classified	 as	 glioblastoma,	
medulloblastoma,	diffuse	astrocytoma	(WHO	II),	primitive	neuroectodermal	tumour	(PNET)	
and	atypical	teratoid/rhabdoid	tumour	(ATRT).		
	
There	 were	 two	 patients	 with	 an	 underlying	 coagulopathy:	 one	 had	 idiopathic	
thrombocytopenic	purpura	(thrombocyte	count	3000/	microliter)	and	the	other	had	Vitamin	
K	 deficiency	 due	 to	 infantile	 obstructive	 cholangiopathy.	 Both	 patients	with	 coagulopathy	
were	younger	than	one	year.		
	
Other	aetiologies	 included	severe	acute	 infection	 (Herpes	simplex	virus	 (HSV)	encephalitis)	
(n=1),	chronic	lung	disease	of	unknown	aetiology	with	multiorgan	failure	in	the	course	of	a	
septic	 shock	 (n=1)	 and	 haemato-oncological	 diseases	 (n=2;	 hepatocellular	 carcinoma	with	
brain	metastases	(n=1),	acute	myeloid	leukaemia,	pulmonary	invasive	aspergillosis	with	need	
of	 cardiopulmonary	 resuscitation	 (n=1)).	 In	 one	 child,	 the	 underlying	 aetiology	 for	 the	
spontaneous	 ventricular	 bleeding	 remained	 unclear	 besides	 extensive	 diagnostic	 work-up	
including	 computed	 tomography	 (CT),	 CT	 angiography,	 magnetic	 resonace	 angiography	
(MRA),	 conventional	 cerebral	 angiography	 (CCA)	 and	 laboratory	 testing	 for	 coagulation	
problems	and	vasculitis.		
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With	respect	to	number	of	risk	factors,	20	patients	had	a	single	risk	factor,	four	patients	had	
a	 severe	 underlying	 disease	with	 in	 the	 clinical	 course	 presumed	multiple	 risk	 factors	 and	
one	child	had	no	known	risk	factor.		
	
Treatment	
Treatment	 decision	 was	 based	 on	 the	 initial	 presentation	 of	 the	 child	 and	 underlying	
aetiology.	 17	 patients	 underwent	 neurosurgical	 intervention,	 one	 patient	 endovascular	
(embolization	of	an	AVM)	and	seven	children	conservative	treatment.			
Short-term	Outcome	
In	 our	 cohort	 two	 patients	 died.	 Both	 patients	 suffered	 from	 a	 severe	 underlying	 disease	
(severe	 chronic	 lung	 disease	 and	 infantile	 obstructive	 cholangiopathy)	 with	 intracranial	
bleeding	 as	 a	 result	 of	 an	 extremely	 complicated	 course	 of	 the	 primary	 disease.	 Most	
patients	could	be	discharged	home	(n=18).	Five	children	had	further	in-hospital	treatments	
or	were	transferred	to	a	rehabilitation	clinic.		
Neurological	 examination	 at	 time	 of	 discharge	 was	 normal	 in	 13	 children.	 Neurological	
deficits	 in	 the	 other	 patients	 were	 hemiparesis	 ±	 facial	 palsy	 (n=8),	 ataxia	 (n=1),	 speech	
disturbance	(n=1)	and	impaired	short-term	memory	(n=1).	One	patient	had	multiple	severe	
neurological	sequelae	after	a	brainstem	bleeding.	One	small	 infant	showed	no	neurological	
deficit	but	had	a	poor	prognosis	due	to	a	malignant	brain	tumour	(ATRT)	without	response	
to	 chemotherapy.	 Our	 collected	 data	 do	 not	 provide	 any	 information	 about	 long-term	
outcome.	
	
	
	
	 8	
Discussion	
Treatment	of	children	with	HS	is	not	only	the	preserve	of	neurosurgeons	and	interventional	
neuroradiologists	 and	 should	 involve	 paediatricians/paediatric	 neurologists.	 It	 is	 the	
paediatrician`s	 responsibility	 as	 the	 first	medical	 contact	 to	 know	when	 to	 think	 about	HS	
and	 what	 to	 do	 as	 the	 first	 diagnostic	 steps	 in	 uncovering	 the	 most	 likely	 underlying	
aetiologies.			
In	 our	 cohort,	 most	 children	 presented	 with	 vomiting,	 headache	 and	 an	 altered	 level	 of	
consciousness.	 This	 result	 is	 similar	 to	 literature	 where	 headache	 is	 one	 of	 the	 main	
presenting	symptom13-23.	Headache	is	very	frequently	reported	in	children	and	adolescents	
in	 the	 general	 population	 and	 is	 one	 of	 the	 most	 common	 reasons	 for	 patients	 seeking	
medical	advice	from	paediatricians.	Sometimes	it	may	be	difficult	to	decide	which	child	with	
headache	needs	more	extensive	investigations	because	they	may	have	intracranial	bleeding.	
However,	 as	 de	 Ribaupierre	 et	 al	 suggest,	 every	 headache	 that	 is	 described	 as	 “worst”	
and/or	has	a	“sudden”	onset	as	well	as	every	headache	with	concomitant	focal	neurological	
deficits	should	immediately	lead	to	further	investigations	17.		
In	 younger	 children	 in	 whom	 headache	 may/could	 not	 be	 the	 leading	 (communicated)	
symptom,	 the	 clinical	 presentation	 of	 haemorrhagic	 stroke	 may	 be	 more	 nonspecific.	
Presenting	symptoms	may	 include	vomiting,	 	 irritability,	 reduced	 level	of	consciousness,	or	
seizures.	It	also	follows,	that	well-known	stroke	recognition	tools	like	the	FAST	test,	featuring	
the	 leading	 symptoms	 in	 arterial	 ischaemic	 stroke	 (facial	 palsy,	 hemiparesis	 and	 speech	
disturbance)	are	not	applicable	in	children	with	haemorrhagic	stroke.	To	increase	awareness	
for	 both	 ischaemic	 and	 haemorrhagic	 stroke,	 the	 paediatric	 stroke	 working	 group	 of	 the	
Ludwig-Maximilians-University	 Munich	 developed	 a	 pocket	 card	 for	 paediatricians	 called	
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MERCS	(=	Munich	early	recognition	of	childhood	stroke)	highlighting	 leading	symptoms	for	
both	stroke	types	on	the	front	and	back	of	the	pocket	card	(see	supplemental	material).	 
	
In	our	cohort,	a	cranial	CT	as	first	imaging	was	performed	in	64%	of	the	children.	CT	remains	
the	 imaging	 modality	 of	 first	 choice	 in	 a	 clinically	 unstable	 child	 with	 a	 reduced	 level	 of	
consciousness.	 CT	 is	 widely	 available,	 quick	 and	 usually	 does	 not	 require	 anaesthesia	 in	
children.	 It	 provides	 information	 about	 the	 type	 of	 bleeding	 (intraparenchymal	 vs.	
ventricular	vs.	subarachnoid),	the	size	of	the	haemorrhage	and	the	presence	of	mass	effect	
and	sometimes	reveals	information	about	aetiology	–	all	of	which	is	essential	information	to	
guide	emergency	neurosurgical	treatment.		Outside	the	emergency	situation,	an	MRI	/MRA	
is	required	as	part	of	the	diagnostic	work-up	to	identify	or	exclude	a	vascular	malformation	
as	an	underlying	cause	and	–	with	respect	to	the	known	insufficient	diagnostic	yield	of	non-
invasive	 imaging	 -	 in	 some	 cases	 (especially	 in	 patients	with	 unknown	 aetiology)	 a	 CCA	 is	
necessary	 24.	 But	 even	 a	 complete	 imaging	 and	 laboratory	 diagnostic	work-up	may	 fail	 to	
detect	the	underlying	reason	for	the	bleeding	(in	our	cohort	n=1).	One	reason	could	be,	that	
the	 	 the	 vascular	 anomaly	 is	 obliterated	 by	 the	 haemorrhage	 and	 therefore	 “invisible”	 in	
post-hoc	investigations.	Diagnostic	work-up	may	also	remain	incomplete	in	patients	with	an	
unfavourable	outcome.		
	
With	respect	to	the	underlying	risk	factors,	our	study	concurs	with	the	published	literature:	
vascular	 diseases	 are	 the	 predominant	 risk	 factor	 for	 intracranial	 bleeding	 in	 a	 paediatric	
population	 (52%	 in	 our	 study	 vs	 7-91%	 in	 the	 literature)	 13-23.	 	 In	 our	 cohort,	 vascular	
malformation	were	more	common	in	elder	children	and	were	not	present	in	the	first	year	of	
life.	 This	 is	 a	 relevant	 information	 with	 reference	 to	 the	 required	 diagnostic	 work	 up,	 as	
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investigation	 for	 coagulation	 problems,	 infections	 and	 malignancies	 (including	 brain	
tumours)	then	becomes	more	important	in	the	younger	age	group.	Aneurysms,	as	one	of	the	
three	main	 vascular	 risk	 factors	 besides	 AVM	 and	 cavernoma,	 were	 not	 described	 in	 our	
cohort,	probably	due	to	the	small	cohort	size.	In	some	children,	intracranial	haemorrhage	is	
described	 as	 the	 initial	 symptom	 of	 a	 brain	 tumour18,	 20.	 The	 definition	 of	 haemorrhagic	
stroke	 related	 to	 a	 brain	 tumour	 is	 imprecise	 and	 not	 consistent.	We	 decided	 to	 exclude	
patients	who	bled	into	a	brain	tumour	(n=8)	and	only	described	patients	with	a	brain	tumour	
who	bled	into	brain	parenchyma,	the	ventricles	or	subarachnoid	space	(n=5).	One	study	with	
high	percentages	of	children	with	brain	tumour	as	an	underlying	aetiology	included	patients	
who	 had	 bled	 into	 a	 brain	 tumour	 18.	 One	 other	 study	 did	 not	 provide	 clear	 information	
about	whether	haemorrhage	was	 into	or	outside	the	brain	tumour,	merely	describing	 it	as	
being	 associated	 with	 a	 brain	 tumour	 20.	 Nevertheless,	 the	 proportion	 of	 children	 with	 a	
brain	 tumour	 as	 underlying	 disease	 (20%)	 in	 our	 cohort	 remains	 high	 compared	 to	 other	
studies	 (up	 to	 15%).	 As	 our	 university	 hospital	 is	 a	 center	 for	 paediatric	 oncology	 and	
haematology,	 this	 may	 be	 the	 reason	 for	 the	 higher	 percentages	 compared	 to	 non-
specialized	clinics.	With	respect	 to	 the	number	of	 risk	 factors,	HS	differs	 from	AIS:	Whilest	
childhood	 AIS	 is	 known	 to	 be	 a	 “multiple	 risk”	 disease	 and	 requires	 extensive	 diagnostic	
work	 up,	most	 children	with	 HS	 show	 a	 single	 risk	 factor	with	 exception	 of	 children	with	
severe	underlying	multiorgan	diseases	and	complex	medical	treatment	prior	the	intracranial	
haemorrhage.	Apart	from	that,	the	percentage	of	so	called	cryptogenic	strokes	seems	lower	
in	HS	compared	to	AIS.		
	
An	 intracranial	 haemorrhage	 is	 a	 possible	 but	 rare	 complication	 in	 patients	 with	 HSV	
encephalitis	 25.	 Hypotheses	 regarding	 the	 underlying	 pathological	mechanisms	 include	 the	
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presence	 of	 a	 small	 vessel	 vasculitis,	 raised	 intracranial	 pressure	 or	 damaged	 brain	 tissue	
being	 more	 vulnerable	 to	 bleeding	 or	 a	 combination	 of	 both	 altered	 parenchyma	 and	
vessels.	 It	 is	 important	to	know,	that	the	bleeding	may	occur	even	in	children	treated	with	
antiviral	agents	and	the	treating	paediatrician	should	have	a	bleeding	complication	in	mind	
in	every	child	who	has	a	secondary	neurological	deterioration.	The	patient	in	our	cohort	with	
HSV	was	a	15	year	old	boy	with	an	acute	clinical	deterioration	(worst	headache,	nausea	and	
sinus	bradycardia)	and	large	haemorrhage	in	the	temporal	lobe	on	day	four	after	admission	
and	the	initiation	of	antiviral	treatment	with	acyclovir.		
This	was	not	an	epidemiological	study	and	therefore	the	patient	population	studied	will	have	
been	subject	to	selection	biases	that	 influenced	their	referral	to	our	hospital.	For	example,	
Ludwig-Maximilians-University	Hospital	is	a	paediatric	onclogy	centre	and	the	relatively	high	
incidence	 of	malignancy	 as	 an	 underlying	 cause	 of	 HS	 probably	 reflects	 this	 selction	 bias.	
Other	selection	biases,	like	the	referral	of	adolescents	to	adult	stroke	units	or	neurosurgery	
departments,	may	be	applied,	but,	we	believe	that	the	range	of	underlying	aetiologies	that	
we	 found	 reflect	 the	 true	 range	 even	 if	 the	 proportions	 may	 have	 been	 different	 in	 a	
population	based	study.	
Our	 retrospective	 study	only	provides	data	about	 short-term	outcome.	 	At	 the	end	of	 the	
acute	 care	 phase,	 52%	 of	 the	 patients	 had	 no	 neurological	 deficit	 and	 72%	 could	 be	
discharged	home.	But	without	using	a	standardized	neurological	examination	instrument	like	
the	Pediatric	Stroke	Outcome	Measure	(PSOM)	and	because	of	missing	short-	or	long-term	
follow	up	data,	these	results	are	barely	comparable	to	other	studies.	Beslow	et	al	found	an	
abnormal	neurological	examinationa	after	a	median	follow	up	time	of	3.5	months	in	71%	of	
children	after	HS	15.	Recently,	a	rehabilitation	center-based	retrospective	study	focused	on	
long-term	outcome	of	128	children	after	childhood	AIS	and	HS.	In	general,	they	saw	better	
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motor	 neurological,	 functional	 and	 academic	 outcomes	 after	 HS	 (versus	 AIS)	 at	 time	 of	
discharge	 from	 the	 rehabilitation	 department	 26.	 	 However,	 at	 time	 of	 discharge	 (median	
time	since	stroke	of	4.7	months),	59.3%	of	children	with	HS	showed	some	degree	of	motor	
deficit	and	35.8%	required	special	education	after	a	median	follow-up	period	of	43	months.	
Further	prospective	studies	or	registry	based	data	are	required	to	capture	all	children	with	
childhood	HS	in	order	to	describe	accurately	long-term	outcomes	and	how	these	outcomes	
are	 influenced	by	underlying	aetiology,	acute	 treatment	and	 rehabilitative	 treatment	after	
discharge	from	the	acute	hospital	setting.		
	
Conclusion	
HS	 constitutes	 approximately	 40%	 of	 all	 childhood	 strokes	 and	 may	 lead	 to	 significant	
morbidity	 and	 mortality.	 The	 knowledge	 of	 the	 leading	 clinical	 symptoms,	 aetiology	 and	
necessary	diagnostic	steps	are	essential	for	quick	emergency	management	and	professional	
discussion	in	a	multidisciplinary	neurovascular	team.	As	HS	differs	from	AIS	in	most	aspects,	
the	 training	 of	 caregivers	 should	 not	 be	 limited	 to	 the	 recognition	 of	 AIS	 and	 the	
development	of	paediatric	 stroke	recognition	 tools	 should	 include	basic	 information	about	
the	 clinical	 presentation	 of	 children	 with	 intracranial	 bleeding.	 With	 respect	 to	 further	
research,	a	first	important	step	for	comparable	cohort	studies	should	be	a	clear	definition	of	
HS	in	the	paediatric	population	and	a	consistent	use	of	ICD-10	coding.	
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What	is	already	known	on	this	topic	
- Haemorrhagic	 stroke	 in	 children	 is	 rare,	 but	 constitutes	 approximately	 40%	 of	 all	
childhood	strokes	and	may	lead	to	significant	morbidity	and	mortality	
- Vascular	 malformations	 are	 the	 most	 common	 underlying	 risk	 factors	 for	
spontaneous	intracranial	bleeding	in	childhood	
- (Interventional)	 neuroradiology	 and	 neurosurgery	 play	 a	 crucial	 role	 in	 the	
neurovascular	treatment	team	
	
What	this	study	adds	
- Symptoms	vary	by	age	(headache	in	children	and	seizures	and	non-specific	syptoms	
in	infants)	
- Compared	to	arterial	ischaemic	stroke,	haemorrhagic	stroke	is	a	mono-risk	disease	
- Paediatricians	 are	 the	 first	 medical	 contact	 person	 for	 children	 with	 headache,	
vomiting	 and	 altered	 level	 of	 conciousness	 –	 the	 most	 presenting	 symptoms	 of	
haemorrhagic	stroke	
- The	 development	 of	 pediatric	 stroke	 recognition	 tools	 should	 provide	 both	
information	about	ischaemic	and	haemorrhagic	stroke	
- Intracranial	 bleeding	 due	 to	 a	 vascular	 malformation	 is	 rare	 in	 infants	 and	 young	
children	and	requires	thorough	diagnostic	work	up	with	a	paediatric	expertise	
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Tables:		
	
	
	
ICD-10	code	 	I61.X	(I61.0-I61.9)	 intracerebral	haemorrhage	I60.X	(I60.0-I60.9)	 subarachnoid	haemorrhage	I62.9		 Intracranial	haemorrhage	(non-traumatic),	unspecified	I64	 stroke,	not	specified	as	haemorrhage	or	infarction	I67.5	 Moyamoya	disease	I67.1	 cerebral	aneurysm,	non-ruptured	Q28.2	 Arteriovenous	malformation	of	cerebral	vessels	Q28.3	 Other	malformations	of	cerebral	vessels	D18.0	 haemangioma,	intracranial	D43.X	+	R58	 Neoplasm	 of	 uncertain	 or	 unknown	 behaviour	 of	 brain	 and	 central	nervous	system	+	haemorrhage,	not	elsewhere	classified	C71.X	+	R58	 malignant	neoplasm	of	brain	+	haemorrhage,	not	elsewhere	classified		
Table	1:	ICD-10	codes	for	case	identification	
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Table	2:	basic	demographic	and	clinical	data	in	n=25	children	with	HS		
Table	2:	Basic	demographic	and	clinical	data	(n=25)	
	
Variable	
	
n		(%)	
	
Sex	(male)	
	
11	(44%)	
	
Age	(years)	
<1	
1-5	
6-18	
	
	
3	(12%)	
4	(16%)	
18	(72%)	
	
First	event	
	
23	(92%)	
	
Symptoms	 	
vomiting	
headache	
altered	level	of	conciousness	
brainstem	symptoms	
seizure	
hemiparesis	
ataxia	
facial	palsy	
other	cranial	nerve	symptoms	
speech	deficit	
irritability	
fever	
signs	of	increased	intracranial	pressure	
no	symptoms,	incidental	finding	
	
12	(48%)	
10	(40%)	
8	(32%)	
4	(16%)	
7	(28%)	
3	(12%)	
2	(8%)	
1	(4%)	
2	(8%)	
1	(4%)	
1	(4%)	
1	(4%)	
1	(4%)	
3	(12%)	
	
First	Imaging	
cCT/cCTA	
cMRI/cMRA	
Cranial	ultrasound	
Unknown	
	
	
16	(64)	
7	(28%)	
1	(4%)	
1	(4%)	
	
Aetiology	
AVM	
cavernoma	
brain	tumor		
others	(coagulopathy,	infection,	medication,	
malignancy)	
	
	
6	(24%)	
7	(28%)	
5	(20%)	
7	(28%)	
	
Treatment	
conservative	
enodovascular	
neurosurgery	
	
	
	
7	(28%)	
1	(4%)	
17	(68%)	
	
Discharge	
further	rehabilitation/treatment	in	a	hospital	
home	
died		
	
	
5	(20%)	
18	(72%)	
2	(8%)	
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Table	3:	Characteristics	of	n=13	children	with	vascular	diseases		
	
Table	3:	Vascular	diseases	(n=13)	
	
	 AVM		
(n=6)	
	
Cavernoma	
(n=7)	
n	(%)	
	
n	(%)	
	
Sex	(male)	 1	(17%)	
	
4	(57%)	
	
Age	(years)	
<	1		
1-5		
6-18		
	
-	
2	(33%)	
4	(67%)	
	
	
-	
1	(14%)	
6	(86%)	
	
Symptoms	
headache	
seizure	
altered	level	of	conciousness		
hemiparesis	
facial	palsy	
other	cranial	nerve	symptoms	
brainstem	symptoms	
vomiting	
speech	deficit	
no	symptoms,	incidental	finding	
	
	
3	(50%)	
2	(40%)	
3	(50%)	
2	(40%)	
1	(17%)	
2	(40%)	
1	(17%)	
4	(67%)	
1	(17%)	
-	
	
	
2	(29%)	
4	(57%)	
-		
-		
-	
-	
-	
-		
-	
2	(29%)	
	
First	imaging	
cCT/cCTA	
cMRI/cMRA	
unknown	
	
4	(67%)	
2	(33%)	
-	
	
	
1	(14%)	
5	(71%)	
1	(14%)	
	
Conventional	angiography	
	
4	(67%)	
	
1	(14%)	
	
Emergency	Treatment	
neurosurgery/craniectomy	
	
2	(33%)	
	
-	
Treatment	
Neurosurgery	
endovascular	
conservative	
	
5	(83%)	
1	(17%)	
-	
	
	
5	(71%)	
-	
2	(29%)	
	
Familiar		
	
-	 2	(29%)	
	
Discharge	
further	rehabilitation/treatment	in	a	hospital	
discharged	home	
	
1	(17%)	
5	(83%)	
	
-	
7	(100%)	
	
